Approval · Notice of Compliance 25487 · 2021
ASACOL: Notice of Compliance 25487
Issued March 19, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25487
- Date
- March 19, 2021
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the product monograph with new safety information and to update the format to the 2016 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASACOL | Not yet assigned | — |
Medicinal ingredients
- MESALAZINE 400 MG per TAB